Position in ESPR
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$0
+$0 QoQ
Shares Held
11,802
-0.2% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
7 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $96,211,937 across 30 Drug Manufacturers - Specialty & Generic names. ESPR ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
503,917 | $36,211,475 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
348,043 | $8,565,338 | |
| 3 | VTRS |
Viatris Inc
|
532,076 | $8,449,366 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
15,582 | $8,442,795 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
46,762 | $7,881,267 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
211,326 | $3,062,113 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
71,898 | $2,602,707 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
147,185 | $2,547,772 |
All Filings in ESPR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 11,802 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | — | 11,821 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | — | 15,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | — | 50,745 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | — | 159,447 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | — | 182,500 | Shares | Sole | 2024-08-13 | |
| 2023-03-31 | — | 17,334 | Shares | Other | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||